Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinoma
Open Access
- 1 October 2017
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 68, 87-91
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implantsBMC Cancer, 2013
- Type-Specific Cell Line Models for Type-Specific Ovarian Cancer ResearchPLOS ONE, 2013
- Fallopian tube precursors of ovarian low‐ and high‐grade serous neoplasmsHistopathology, 2012
- Low‐grade serous carcinomas of the ovary contain very few point mutationsThe Journal of Pathology, 2011
- High Throughput Interrogation of Somatic Mutations in High Grade Serous Cancer of the OvaryPLOS ONE, 2011
- BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous CarcinomasThe American Journal of Pathology, 2010
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying TheoryAmerican Journal of Surgical Pathology, 2010
- Analysis of DNA Copy Number Alterations in Ovarian Serous Tumors Identifies New Molecular Genetic Changes in Low-Grade and High-Grade CarcinomasCancer Research, 2009
- Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential TumorsMolecular Cancer Research, 2008
- Serous Tubal Intraepithelial Carcinoma: Its Potential Role in Primary Peritoneal Serous Carcinoma and Serous Cancer PreventionJournal of Clinical Oncology, 2008